Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for cx 4945 (compound)
Most Correlated Studies
- Breast cancer MB-468 cells treated with CX4945 compound
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Most Relevant Literature
- Anti-adipogenic and Pro-lipolytic Effects on 3T3-L1 Preadipocytes by CX-4945, an Inhibitor of Casein…
- CX-4945 inhibits fibroblast-like synoviocytes functions through the CK2-p53 axis to reduce rheumatoi…
- Successful Partnerships: Exploring the Potential of Immunogenic Signals Triggered by TMZ, CX-4945, a…
- Sequence of CX-4945 and Cisplatin Administration Determines the Effectiveness of Drug Combination an…
- The Casein Kinase 2 Inhibitor CX-4945 Promotes Cholangiocarcinoma Cell Death Through PLK1.
Most Relevant Clinical Trials
- A Study of Silmitasertib (CX-4945) in Healthy Subject
- Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or…
- Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangioc…
- Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcin…
- Dose-escalation Study of Oral CX-4945
